Novartis data show nearly 80% of RMS patients treated with ofatumumab had no evidence of NEDA-3
Earlier initiation with Kesimpta resulted in a more than three-fold increased likelihood of maintaining NEDA-3 throughout the study
Earlier initiation with Kesimpta resulted in a more than three-fold increased likelihood of maintaining NEDA-3 throughout the study
States were also strongly advised to strictly monitor epidemiological profile of admitted COVID patients
Doctors will study for a Master of Surgery or Master of Medicine degree at Edge Hill University.
73% have cited fears like losing eyesight, painful procedure or long recovery period when it comes to cataract surgeries
Dr. Reddy's acquired the Eton portfolio for an upfront payment of approximately $5 million in cash, plus contingent payments of up to $45 million.
The Minister directed officials to continue to focus on surveillance and on Whole Genome Sequencing to scan for any possible mutation and also directed for monitoring hospitalizations due to COVID-19 and SARI/ILI cases
Tabrecta is the number one prescribed targeted therapy for advanced NSCLC with alterations leading to METex14 skipping globally
Most recently, she served as chief human resources officer at Vyripharm Enterprises.
LYNPARZA is approved in the U.S. for patients with HRR gene-mutated mCRPC (BRCA-mutated and other HRR gene mutations)
Alliances with CVS Health and Javara further embed clinical research into the community healthcare setting, expanding access to patient populations across the U.S to increase diversity in clinical trials
Subscribe To Our Newsletter & Stay Updated